Robert Nelsen, Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 226,678 shares at $54.17 ($11.2M) on 2017-02-21, disclosed to the SEC on 2017-02-23.
Open-market sale of $11.2M AGIO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.56 | 34,650 | $1.8M | 15.7% |
| 2 | $54.17 | 1,780 | $96K | 0.9% |
| 3 | $54.17 | 1,780 | $96K | 0.9% |
| 4 | $49.90 | 46,938 | $2.3M | 21.0% |
| 5 | $49.90 | 46,938 | $2.3M | 21.0% |
| 6 | $50.35 | 1,000 |
| $50K |
| 0.5% |
| 7 | $47.73 | 42,596 | $2.0M | 18.2% |
| 8 | $47.73 | 42,596 | $2.0M | 18.2% |
| 9 | $48.75 | 8,400 | $409K | 3.7% |
| Total | $49.21 avg | 226,678 | $11.2M | 100% |
| Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |